Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
$19M Funds Digital Twins to Defend US Hospitals
Tech & Innovation $19M Funds Digital Twins to Defend US Hospitals

The intricate web of interconnected medical devices and patient data systems that forms the backbone of modern healthcare is also its greatest vulnerability, creating a vast attack surface for cybercriminals. The healthcare sector has become a prime target, where a single breach can disrupt

Large Study Finds No Stomach Cancer Risk From PPIs
Research & Development Large Study Finds No Stomach Cancer Risk From PPIs

For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among

UTSW Debuts Liver Chemo Bath for Rare Eye Cancer
Research & Development UTSW Debuts Liver Chemo Bath for Rare Eye Cancer

Today we're speaking with Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping modern medicine. We'll be delving into a remarkable breakthrough in oncology: a new, highly targeted procedure for treating metastatic uveal melanoma, a rare and aggressive eye

Can Microbes Become Our Chemical Factories?
Biotech & Bioprocessing Can Microbes Become Our Chemical Factories?

The quest for sustainable manufacturing has led scientists to an unlikely workforce: single-celled organisms meticulously reprogrammed to produce some of the world's most valuable chemicals. This burgeoning field of synthetic biology is unlocking the potential of microbes to serve as miniature,

AI Deciphers Complex Genetics of Huntington's Onset
Tech & Innovation AI Deciphers Complex Genetics of Huntington's Onset

For families grappling with the hereditary specter of Huntington's disease, the certainty of a genetic diagnosis has always been shadowed by a profound and distressing uncertainty about when its devastating symptoms will begin. This devastating neurodegenerative disorder, caused by a known mutation

Novartis Urges Global Policy Shift for Life Sciences
Biotech & Bioprocessing Novartis Urges Global Policy Shift for Life Sciences

In a stark pronouncement that reverberates through the global health and economic sectors, pharmaceutical leader Novartis, in a joint analysis with the Eurasia Group, has declared the current global policy framework for life sciences dangerously outdated and on a collision course with future

Can a Wearable Device Restore a Lost Voice?
Tech & Innovation Can a Wearable Device Restore a Lost Voice?

The sudden loss of speech following a stroke can be a profoundly isolating experience, trapping clear thoughts and urgent needs behind a physical inability to articulate them. For many survivors, the mind remains sharp, yet the connection to the muscles of the throat and mouth is severed, leading

AI Platform to Revive Shelved Rare Disease Therapies
Research & Development AI Platform to Revive Shelved Rare Disease Therapies

A groundbreaking collaboration is set to address a critical paradox in modern medicine, where potentially life-saving therapies for ultra-rare diseases are abandoned not for lack of scientific merit, but due to insufficient commercial appeal. The American Society of Gene & Cell Therapy (ASGCT) and

AI-Powered Chart Review – Review
Tech & Innovation AI-Powered Chart Review – Review

In the digital age of medicine, clinicians are paradoxically drowning in an ocean of patient data while simultaneously thirsting for clear, actionable insights at the point of care. The emergence of AI-Powered Chart Review represents a significant advancement in the healthcare technology sector,

Are We Winning the Fight Against Cervical Cancer?
Research & Development Are We Winning the Fight Against Cervical Cancer?

Today we are speaking with Ivan Kairatov, a biopharma expert whose work at the intersection of public health and cancer epidemiology sheds light on one of the world’s most preventable cancers. We’ll be exploring the complex story behind cervical cancer: a disease for which we have the tools to

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later